Featured Research

from universities, journals, and other organizations

Why and how anti-retroviral therapy works even against HIV cell-to-cell transmission

Date:
February 27, 2014
Source:
PLOS
Summary:
A new study tested a panel of anti-HIV drugs for their ability to suppress cell-to-cell transmission of the virus. The results reveal differences between different drugs, explain why and how anti-retroviral therapy does work, and have implications for the prevention of drug resistance as well as the development of new effective anti-HIV drugs.

The discovery of direct cell-to-cell transmission of HIV, and the finding that some anti-HIV drugs don't seem active against virus that spreads that way, have caused questions and concern. A study published on February 27th in PLOS Pathogens tested a panel of anti-HIV drugs for their ability to suppress cell-to-cell transmission of the virus. The results reveal differences between different drugs, explain why and how anti-retroviral therapy (ART) does work, and have implications for the prevention of drug resistance as well as the development of new effective anti-HIV drugs.

Luis Agosto, Walther Mothes, and colleagues, from Yale University, New Haven, USA, established an experimental system that can measure the efficiency of cell-free and direct cell-to-cell transmission of HIV and directly compare the two modes of transmission. Cell-free transmission means new virus particles bud from one cell and then travel through inter-cellular space to find a target cell to which they bind to and subsequently infect. Direct cell-to-cell transmission involves close contact of an infected and an uninfected cell through a so-called virological synapse -- an organized contact area which concentrates virus particles and cellular HIV entry points.

The researchers systematically tested the efficiency of anti-HIV drugs, including 6 different nucleoside analog reverse transcriptase inhibitors (NRTIs), 4 non-nucleoside analog reverse transcriptase inhibitors (NNRTIs), 4 entry inhibitors (ENT-Is), and 4 proteinase inhibitors (PIs), in both transmission situations. They found that while some NRTIs were unable to efficiently inhibit virus during cell-to-cell transmission, NNRTIs, ENT-Is, and PIs remained highly effective. And when they combined two inactive NRTIs, they regained potent antiretroviral activity during cell-to-cell transmission.

There are many more infectious virus particles near a target cell during cell-to-cell transmission, raising the "multiplicity of infection," or MOI, the ratio of the number of infectious particles to the number of target cells present in a defined space. When the scientists changed the MOI in their experimental system by adding more viruses to a space for cell-free transmission, they found that the different drugs behaved just like when added to cell-to-cell transmission, i.e. some NRTIs were, by themselves, ineffective in suppressing the virus. In these cases, a higher drug concentration was required to suppress an elevated number of particles. However, when two such drugs were combined, they became effective again.

These results explain how ART regimens, which are all combination therapies (e.g. of 2 NRTIs plus 1 NNRTI or PI) are capable of suppressing HIV, even if some or most of the viral transmission occurs through direct cell-to-cell contact. However, they also warn that cell-to-cell transmission could contribute to the rise of drug-resistant virus if patients don't take all their drugs as prescribed.

Because all drugs that could suppress HIV during cell-to-cell transmission were effective because they could efficiently suppress the high local MOI at virological synapses, the authors suggest that "highly effective drug regimens, either single or in-combination therapies, must exhibit MOI independence." They go on to propose that, "testing the effectiveness of antiretroviral inhibitors against increasing MOI provides a simple assay and a valuable tool for screening existing and novel drugs and future drug combinations prior to clinical testing."


Story Source:

The above story is based on materials provided by PLOS. Note: Materials may be edited for content and length.


Journal Reference:

  1. Luis M. Agosto, Peng Zhong, James Munro, Walther Mothes. Highly Active Antiretroviral Therapies Are Effective against HIV-1 Cell-to-Cell Transmission. PLoS Pathogens, 2014; 10 (2): e1003982 DOI: 10.1371/journal.ppat.1003982

Cite This Page:

PLOS. "Why and how anti-retroviral therapy works even against HIV cell-to-cell transmission." ScienceDaily. ScienceDaily, 27 February 2014. <www.sciencedaily.com/releases/2014/02/140227191207.htm>.
PLOS. (2014, February 27). Why and how anti-retroviral therapy works even against HIV cell-to-cell transmission. ScienceDaily. Retrieved September 21, 2014 from www.sciencedaily.com/releases/2014/02/140227191207.htm
PLOS. "Why and how anti-retroviral therapy works even against HIV cell-to-cell transmission." ScienceDaily. www.sciencedaily.com/releases/2014/02/140227191207.htm (accessed September 21, 2014).

Share This



More Health & Medicine News

Sunday, September 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins